
2026-10-01
When you buy medical grade 45S5 bioglass, you are securing the gold standard in bioactive materials for bone regeneration and tissue engineering. As a specialized provider committed to scientific rigor, Jinan Meiyi Biotechnology Co., Ltd. ensures that the high-purity 45S5 compositions we supply strictly adhere to ASTM and ISO standards. This guarantees consistent bioactivity, mechanical integrity, and regulatory compliance for clinical and industrial applications. Our robust supply chain guarantees traceability from raw material sourcing to final particle size distribution, supporting R&D labs, medical device manufacturers, and dental implant producers with reliable, scalable solutions.
45S5 Bioglass, originally developed by Professor Larry Hench at the University of Florida, is the first synthetic material designed to bond directly with living bone. The name “45S5” refers to its specific composition: 45% silica (SiO2) and a 5:1 ratio of calcium to phosphorus. This unique stoichiometry allows the material to undergo a series of surface reactions when exposed to physiological fluids, leading to the formation of a hydroxycarbonate apatite (HCA) layer.
This HCA layer is chemically and structurally equivalent to the mineral phase of human bone. It is this biological mimicry that enables true osseointegration, where the implant or graft material becomes indistinguishable from the surrounding native tissue over time. For procurement officers and engineers, understanding this chemical baseline is critical when evaluating suppliers.
The efficacy of 45S5 bioglass relies on precise weight percentages of four key oxides. Deviations in these ratios can significantly alter the degradation rate and bioactivity. When you source this material, verifying the Certificate of Analysis (CoA) against these standard values is essential:
Any supplier claiming to offer “45S5” must demonstrate adherence to these exact proportions. Minor variations often result in materials classified simply as “bioactive glasses” rather than the specific, clinically proven 45S5 formulation.

In the medical device and regenerative medicine sectors, material consistency is not just a quality preference; it is a regulatory necessity. Buying medical grade 45S5 bioglass from a qualified supplier mitigates risk across your product development lifecycle. Partnering with a company like Jinan Meiyi Biotechnology, which operates under strict quality assurance frameworks and partners with certified manufacturers adhering to international standards such as ISO 13485, ensures that manufacturing environments, quality control processes, and documentation meet global benchmarks.
One of the most significant challenges in scaling bioactive glass applications is maintaining uniformity across production batches. Inconsistent particle size distribution or chemical impurities can lead to unpredictable degradation rates in vivo. A rigorous quality assurance framework involves statistical process control (SPC) to ensure that every kilogram of bioglass shipped meets the same specifications as the previous one.
Key quality parameters monitored include:
For companies developing Class II or Class III medical devices, the ability to trace raw materials back to their source is mandatory for FDA 510(k) submissions or CE Marking under the EU MDR. At Jinan Meiyi Biotechnology, our operational model prioritizes transparency and reliability. We provide full lot traceability, including raw material certificates, melting logs, and milling records from our certified manufacturing partners. This documentation streamlines your regulatory approval process by providing auditable proof of material safety and consistency.

When evaluating proposals to buy medical grade 45S5 bioglass, technical data sheets must align with established industry benchmarks. Below is a detailed breakdown of the typical physical and chemical properties expected from a premium supplier.
| Parameter | Specification | Test Method |
|---|---|---|
| Chemical Composition | 45% SiO2, 24.5% CaO, 24.5% Na2O, 6% P2O5 | X-Ray Fluorescence (XRF) |
| Physical State | Amorphous Glass (Non-crystalline) | X-Ray Diffraction (XRD) |
| Particle Size Range | Customizable: <45µm, 45-90µm, 90-150µm, etc. | Laser Diffraction (ISO 13320) |
| Bioactivity Index | Class A (Forms bond with bone within minutes) | In vitro Simulated Body Fluid (SBF) Test |
| Heavy Metals | <10 ppm total impurities | ICP-MS |
| Moisture Content | <0.5% | Thermogravimetric Analysis (TGA) |
The particle size of 45S5 bioglass directly influences its application performance. Smaller particles have a higher specific surface area, leading to faster ion release and quicker HCA layer formation. However, they may degrade too rapidly for certain load-bearing applications. Larger particles provide structural scaffolding but react more slowly.
Our capabilities allow for precise specification matching to meet these specific granularity requirements, ensuring the material fits your specific device design.
The versatility of 45S5 bioglass has expanded beyond its original use in middle ear ossicles. Today, it is a cornerstone material in various medical disciplines. Understanding these applications helps in selecting the right grade and form factor for your project.
In orthopedics, 45S5 bioglass is used as a bone void filler for non-load bearing defects. It stimulates rapid bone growth, reducing healing time compared to autografts or allografts. It is particularly effective in treating complex fractures, spinal fusion procedures, and revision surgeries where bone stock is compromised.
The material’s ability to bond with both hard and soft tissue makes it invaluable in interfaces where tendon or ligament attachment to bone is required. By promoting fibroblast proliferation, it enhances the integration of soft tissues into the bone matrix.
Dental applications represent one of the largest markets for 45S5 bioglass. It is widely used in:
For dental product manufacturers, the aesthetic neutrality of bioglass (it does not discolor over time) and its ease of mixing with binders make it a preferred choice over some ceramic alternatives.
Recent advancements have highlighted the efficacy of 45S5 bioglass in soft tissue repair. The ions released by the glass (specifically silicon and calcium) have been shown to stimulate angiogenesis (formation of new blood vessels) and collagen production. This makes it highly effective in treating chronic wounds, such as diabetic ulcers and burns, where healing is stalled.
Products incorporating bioglass fibers or meshes can accelerate closure rates and reduce scarring. This application requires ultra-fine fiber forms or specialized composite matrices, demonstrating the need for diverse processing capabilities from your supplier.
Procuring high-quality bioglass requires a strategic approach. It is not merely a commodity purchase; it is a partnership with a material science provider. Here is a step-by-step guide to ensuring you select the right partner.
Before requesting a quote, clearly define the technical needs of your product. Are you developing a putty, a scaffold, or a coating? The required particle size, purity level, and packaging format will vary significantly. For instance, R&D quantities may require sterile, small-batch packaging, while commercial production needs bulk, cost-effective logistics.
Request current ISO 13485 certificates and audit reports. Ask for sample Certificates of Analysis (CoA) from recent batches. Check for compliance with relevant regional regulations, such as REACH in Europe or TSCA in the United States. A transparent supplier like Jinan Meiyi Biotechnology will provide these documents without hesitation, leveraging its disciplined curation methodology to ensure regulatory clarity.
Never commit to a large volume without testing. Request samples that match your specified particle size distribution. Perform in-house tests for:
Evaluate the supplier’s production capacity and lead times. In the medical industry, supply interruptions can halt entire production lines. Ask about their inventory management strategies and contingency plans for raw material shortages. A robust supplier will have multiple sources for high-purity raw chemicals to mitigate risk. Jinan Meiyi Biotechnology leverages a globally integrated and vetted supply chain, maintaining long-term cooperative relationships with internationally recognized suppliers to ensure consistent access to technically advanced materials.
Even experienced procurement professionals can encounter pitfalls when entering the bioglass market. Being aware of these common errors can save time and resources.
To understand the value proposition of 45S5, it is helpful to compare it with other common bone graft substitutes. This comparison highlights why many engineers and clinicians prefer bioglass for specific indications.
| Feature | 45S5 Bioglass | Hydroxyapatite (HA) | Beta-Tricalcium Phosphate (β-TCP) | Autograft (Patient’s Own Bone) |
|---|---|---|---|---|
| Bioactivity | High (Bonding) | Moderate (Osteoconductive) | High (Resorbable) | Gold Standard |
| Osteostimulation | Yes (Gene Activation) | No | No | Yes |
| Resorption Rate | Fast (Replaced by bone) | Very Slow (Years) | Moderate | N/A |
| Supply Availability | Unlimited | Unlimited | Unlimited | Limited (Surgery Required) |
| Risk of Disease Transmission | None | None | None | Low |
| Mechanical Strength | Low (Brittle) | High | Low | High |
As shown in the table, 45S5 Bioglass offers a unique combination of unlimited supply, zero disease risk, and active osteostimulation. While it lacks the initial mechanical strength of HA or autograft, its ability to actively stimulate bone growth and eventually be fully replaced by native tissue makes it superior for regenerative outcomes.
Proper handling of medical grade 45S5 bioglass is crucial to maintain its quality until use. Due to its high reactivity, exposure to humidity can initiate surface changes that diminish performance.
Store bioglass in a cool, dry environment, ideally below 25°C (77°F) with relative humidity under 50%. Keep containers tightly sealed when not in use. Use desiccants in storage areas if necessary. Avoid storing near strong acids or bases that could contaminate the material.
While bioglass is non-toxic, fine particulate matter can be an irritant. Personnel should wear appropriate personal protective equipment (PPE), including N95 masks or respirators, gloves, and eye protection when handling dry powder. Use local exhaust ventilation to minimize airborne dust during weighing or mixing operations.
When stored correctly in original, unopened packaging, medical grade 45S5 bioglass typically has a shelf life of 24 to 36 months. However, this can vary based on packaging integrity. Always check the expiration date on the CoA and perform periodic quality checks if storing for extended periods.
45S5 is a specific composition with 45% silica and a 5:1 calcium-to-phosphorus ratio. Other bioglasses may have higher silica content (e.g., 55S4.6 or 70S30), which makes them dissolve more slowly. 45S5 is the most bioactive and fastest-bonding composition, making it the preferred choice for applications requiring rapid integration.
Yes, 45S5 bioglass has a long history of clinical safety. It has been used in millions of patients worldwide since the 1980s. It is biocompatible, non-toxic, and non-immunogenic. However, it must be manufactured under strict quality controls to ensure purity and absence of contaminants.
Pure 45S5 bioglass is brittle and not suitable for load-bearing applications on its own. It is typically used in non-load bearing voids or mixed with polymers or other ceramics to create composites with enhanced mechanical properties. For load-bearing sites, it is often used in conjunction with metal implants or screws.
We offer custom milling services through our certified partners to meet specific particle size distributions. Contact our technical team with your target D10, D50, and D90 values. We can provide samples for validation before scaling up to full production volumes.
45S5 bioglass is radiopaque, meaning it shows up on X-rays and CT scans, which is beneficial for post-operative monitoring. It is also MRI conditional, meaning it does not create significant artifacts that would obscure diagnostic images, unlike some metal implants.
Headquartered in Jinan, Shandong Province, China, Jinan Meiyi Biotechnology Co., Ltd. is a professional enterprise and a subsidiary of Pacific Kangtai Scientific Instruments (Jinan) Co., Ltd. Dedicated to the research, development support, and commercialization of bioactive technologies, the company serves as a trusted enabler for innovation across the global personal care and aesthetic medicine value chain.
Jinan Meiyi Biotechnology positions itself at the intersection of scientific rigor and market responsiveness. While the company does not engage in direct manufacturing, it functions as a strategic sourcing and quality-assured distribution partner. By leveraging a well-established global supply chain network, Jinan Meiyi maintains long-term cooperative relationships with internationally recognized, ISO-certified manufacturers. This ensures consistent access to technically advanced, regulatory-compliant, and scientifically validated materials.
The company’s core business is structured around two complementary pillars: the supply of cosmetic and bioactive raw materials, and the distribution of premium cosmetics and medical aesthetic products. Within the raw materials segment, Jinan Meiyi focuses exclusively on active ingredients and functional components used in formulation development. All raw materials undergo comprehensive evaluation prior to inclusion in the portfolio, with selection criteria grounded in efficacy data, stability profiles, and compatibility with modern formulation standards.
Key strengths distinguishing Jinan Meiyi Biotechnology include:
Through sustained focus and unwavering commitment to scientific integrity, Jinan Meiyi Biotechnology continues to strengthen its position as a dependable contributor to the global bioactive technology ecosystem, facilitating the translation of bioactive science into real-world consumer and clinical benefits.
Choosing to buy medical grade 45S5 bioglass is a decision that impacts the efficacy of your medical devices and the health of end patients. The material’s unique ability to bond with living tissue offers unparalleled advantages in orthopedics, dentistry, and wound care. However, realizing these benefits requires a supply partner who prioritizes purity, consistency, and regulatory compliance.
As a dedicated provider committed to scientific integrity, Jinan Meiyi Biotechnology is committed to delivering high-quality 45S5 bioglass that meets the rigorous demands of the modern medical industry. From precise chemical composition to controlled particle sizing, our products are engineered to support your innovation and accelerate your path to market.
Do not compromise on quality. Ensure your products perform as intended by sourcing from a provider with proven expertise and authoritative certification.
Ready to optimize your material sourcing? Contact our technical sales team today to request a product datasheet, discuss custom specifications, or schedule a consultation on how our 45S5 bioglass can enhance your product line.
Explore Our Full Range of Bioactive Materials and Technical Solutions